Last 12 months
Inside the activity.
0 purchase rows · 14 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 6 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2004 Filed Apr 2, 2004 18:08 UTC |
PERLMUTTER ROGER MExe VP, Research & Development
|
Tax withholdingCommon Stock | 8,490 | $58.64 | $497,853.60 |
DisclosureSEC source: 0001181431-04-018880 · rrd38474.xml · nonDerivative · entry 1 PERLMUTTER ROGER M · CIK 0001184228 · Exe VP, Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,260 Read SEC document |
| April 01, 2004 Filed Apr 2, 2004 19:39 UTC |
MILETICH JOSEPH PSr VP Rsch & Preclinical Dev
|
Tax withholdingCommon Stock | 1,787 | $58.64 | $104,789.68 |
DisclosureSEC source: 0001181431-04-018955 · rrd38585.xml · nonDerivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,713 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:00 UTC |
SCHAEFFER LEONARD DDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015899 · rrd36762.xml · derivative · entry 2 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:00 UTC |
SCHAEFFER LEONARD DDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015899 · rrd36762.xml · nonDerivative · entry 1 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04)The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one to one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:01 UTC |
CHOATE JERRY DDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015900 · rrd36767.xml · derivative · entry 3 CHOATE JERRY D · CIK 0001099539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:01 UTC |
CHOATE JERRY DDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015900 · rrd36767.xml · nonDerivative · entry 2 CHOATE JERRY D · CIK 0001099539 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous services as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:04 UTC |
BALTIMORE DAVIDDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015901 · rrd36774.xml · derivative · entry 3 BALTIMORE DAVID · CIK 0001185858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:04 UTC |
BALTIMORE DAVIDDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015901 · rrd36774.xml · nonDerivative · entry 2 BALTIMORE DAVID · CIK 0001185858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:10 UTC |
OMENN GILBERT SDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015903 · rrd36769.xml · derivative · entry 2 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:10 UTC |
OMENN GILBERT SDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015903 · rrd36769.xml · nonDerivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. F2 · balance_after: (GSO-03.15.04) Does not include: (i) 159,188 shares of common stock directly owned by reporting person, (ii) 5,250 shares of common stock held by the son of reporting person, and (iii) .5 unit of contractual contingent payment rights arising from the purchase by Amgen Inc. of two Class A intrests of Amgen Clinical Partners, L.P. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:11 UTC |
BIONDI FRANKDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015904 · rrd36775.xml · derivative · entry 2 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:11 UTC |
BIONDI FRANKDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015904 · rrd36775.xml · nonDerivative · entry 1 BIONDI FRANK · CIK 0001032669 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.2004) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:12 UTC |
JOHNSON FRANKLIN P JRDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015905 · rrd36772.xml · derivative · entry 2 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:12 UTC |
JOHNSON FRANKLIN P JRDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015905 · rrd36772.xml · nonDerivative · entry 1 JOHNSON FRANKLIN P JR · CIK 0000904017 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continious service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. F2 · balance_after: (FPJ 03.15.04) Does not include (i) 997,679 shares of common stock directly owned by reporting person; (ii) 720,800 shares of common stock held as indirect ownership by Asset Management Partners (the "Partnership") for which the reporting person is a general partner; (iii) 4 units of contractual contingent payment rights held as indirect ownership by the Partnership arising from the purchase by Amgen Inc. of two Class A interests of Amgen Clinical Partners, L.P., and (iv) 848,888 shares of common stock held as indirect ownership by the spouse of the reporting person. The reporting person disclaims beneficial ownership of spouse's securities and of the Partnership's securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of the spouse's securities for purposes of Section 16 of the Securities Exchange Act of 1934. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:13 UTC |
GLUCK FREDERICK WDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015906 · rrd36771.xml · derivative · entry 3 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:13 UTC |
GLUCK FREDERICK WDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015906 · rrd36771.xml · nonDerivative · entry 2 GLUCK FREDERICK W · CIK 0001184126 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one to one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:14 UTC |
SUELTZ PATRICIA CDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015907 · rrd36761.xml · derivative · entry 2 SUELTZ PATRICIA C · CIK 0001185617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:14 UTC |
SUELTZ PATRICIA CDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015907 · rrd36761.xml · nonDerivative · entry 1 SUELTZ PATRICIA C · CIK 0001185617 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:51 UTC |
RICE DONALD BDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015932 · rrd36766.xml · derivative · entry 3 RICE DONALD B · CIK 0001183516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 21:51 UTC |
RICE DONALD BDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015932 · rrd36766.xml · nonDerivative · entry 2 RICE DONALD B · CIK 0001183516 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:03 UTC |
REASON J PAULDirector
|
GrantNQSO (Right Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015950 · rrd36768.xml · derivative · entry 3 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:03 UTC |
REASON J PAULDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015950 · rrd36768.xml · nonDerivative · entry 2 REASON J PAUL · CIK 0001184127 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RUSs vest (a) immediately for directors who have three years or more of prior continuous service as a director. or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payments is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:04 UTC |
PELHAM JUDITH CDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $859.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015952 · rrd36765.xml · derivative · entry 3 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:04 UTC |
PELHAM JUDITH CDirector
|
GrantRestricted Stock Units | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-015952 · rrd36765.xml · nonDerivative · entry 2 PELHAM JUDITH C · CIK 0001185287 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:34 UTC |
MILETICH JOSEPH PSr VP Rsch & Preclinical Dev
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015974 · rrd36855.xml · derivative · entry 2 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:34 UTC |
MILETICH JOSEPH PSr VP Rsch & Preclinical Dev
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015974 · rrd36855.xml · derivative · entry 1 MILETICH JOSEPH P · CIK 0001184125 · Sr VP Rsch & Preclinical Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:35 UTC |
PERLMUTTER ROGER MExe VP Research & Development
|
GrantNQSO (Right to Buy) · Derivative | 73,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015975 · rrd36860.xml · derivative · entry 2 PERLMUTTER ROGER M · CIK 0001184228 · Exe VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,319 Underlying: Common Stock · 73,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:35 UTC |
PERLMUTTER ROGER MExe VP Research & Development
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015975 · rrd36860.xml · derivative · entry 1 PERLMUTTER ROGER M · CIK 0001184228 · Exe VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:37 UTC |
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
|
GrantNQSO (Right to Buy) · Derivative | 221,639 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015976 · rrd36784.xml · derivative · entry 2 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 221,639 Underlying: Common Stock · 221,639 shares Expires 2011-03-15 F2 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:37 UTC |
SHARER KEVIN WDirector · Chairman of the Bd, CEO & Pres
|
GrantISO (Right to Buy) · Derivative | 3,361 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015976 · rrd36784.xml · derivative · entry 1 SHARER KEVIN W · CIK 0001185618 · Director · Chairman of the Bd, CEO & Pres 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,361 Underlying: Common Stock · 3,361 shares Expires 2011-03-15 F1 · derivative.exercise_date: (KWS 3.15.04) The option is exercisable on March 15, 2005 for 839 shares on March 15, 2006 for 841 shares: and on March 15, 2009 for 1,681 shares. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:39 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015977 · rrd36780.xml · derivative · entry 2 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 22:39 UTC |
BONANNI FABRIZIOSenior VP, Manufacturing
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-015977 · rrd36780.xml · derivative · entry 1 BONANNI FABRIZIO · CIK 0001183903 · Senior VP, Manufacturing 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:05 UTC |
MCNAMEE BRIAN MSr. V.P..Human Resources
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.84 | $0.00 |
DisclosureSEC source: 0001181431-04-015993 · rrd36864.xml · derivative · entry 2 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P..Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:05 UTC |
MCNAMEE BRIAN MSr. V.P..Human Resources
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.84 | $0.00 |
DisclosureSEC source: 0001181431-04-015993 · rrd36864.xml · derivative · entry 1 MCNAMEE BRIAN M · CIK 0001183885 · Sr. V.P..Human Resources 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:11 UTC |
SCOTT DAVID JSr. VP, Gen. Counsel & Secy.
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016000 · rrd36911.xml · derivative · entry 2 SCOTT DAVID J · CIK 0001145154 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:11 UTC |
SCOTT DAVID JSr. VP, Gen. Counsel & Secy.
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016000 · rrd36911.xml · derivative · entry 1 SCOTT DAVID J · CIK 0001145154 · Sr. VP, Gen. Counsel & Secy. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:20 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
GrantNQSO (Right to Buy) · Derivative | 73,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016006 · rrd36779.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,319 Underlying: Common Stock · 73,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:20 UTC |
FENTON DENNIS MEx VP Ops & Corp Compliance
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016006 · rrd36779.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Ex VP Ops & Corp Compliance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:26 UTC |
NANULA RICHARD DExe VP Fin, Strat & Comm & CFO
|
GrantNQSO (Right to Buy) · Derivative | 73,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016010 · rrd36901.xml · derivative · entry 2 NANULA RICHARD D · CIK 0001184629 · Exe VP Fin, Strat & Comm & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,319 Underlying: Common Stock · 73,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:26 UTC |
NANULA RICHARD DExe VP Fin, Strat & Comm & CFO
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016010 · rrd36901.xml · derivative · entry 1 NANULA RICHARD D · CIK 0001184629 · Exe VP Fin, Strat & Comm & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:27 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
GrantNQSO (Right to Buy) · Derivative | 73,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016012 · rrd36905.xml · derivative · entry 2 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,319 Underlying: Common Stock · 73,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible,beginning on March 15,2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:27 UTC |
MORROW GEORGE JExe VP, Global Commercial Ops
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016012 · rrd36905.xml · derivative · entry 1 MORROW GEORGE J · CIK 0001068754 · Exe VP, Global Commercial Ops 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:28 UTC |
DAYEM HASSANSr. V.P. & Chief Info. Officer
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016015 · rrd36908.xml · derivative · entry 2 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 16, 2004 23:28 UTC |
DAYEM HASSANSr. V.P. & Chief Info. Officer
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016015 · rrd36908.xml · derivative · entry 1 DAYEM HASSAN · CIK 0001185619 · Sr. V.P. & Chief Info. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:32 UTC |
MARTIN TIMOTHY OV.P., Planning and Control · Chief Accounting Officer
|
GrantNQSO (Right to Buy) · Derivative | 3,024 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016109 · rrd36858.xml · derivative · entry 1 MARTIN TIMOTHY O · CIK 0001282020 · V.P., Planning and Control · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,024 Underlying: Common Stock · 3,024 shares Expires 2011-03-15 F1 · derivative.exercise_date: (TOM 3.15.04) The option is exercisable in four equal installments commencing March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:47 UTC |
SEIDENBERG BETH CSr VP, Dev & Chief Medical Ofc
|
GrantNQSO (Right to Buy) · Derivative | 48,319 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016115 · rrd36907.xml · derivative · entry 2 SEIDENBERG BETH C · CIK 0001184592 · Sr VP, Dev & Chief Medical Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,319 Underlying: Common Stock · 48,319 shares Expires 2011-03-15 F1 · derivative.exercise_date: (3.15.04) The option becomes exercisable in five as nearly equal annual installments as possible, beginning on March 15, 2005. Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:47 UTC |
SEIDENBERG BETH CSr VP, Dev & Chief Medical Ofc
|
GrantISO (Right to Buy) · Derivative | 1,681 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016115 · rrd36907.xml · derivative · entry 1 SEIDENBERG BETH C · CIK 0001184592 · Sr VP, Dev & Chief Medical Ofc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,681 Underlying: Common Stock · 1,681 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:51 UTC |
LAZARUS STEVENDirector
|
GrantNQSO (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $59.48 | $0.00 |
DisclosureSEC source: 0001181431-04-016116 · rrd36764.xml · derivative · entry 3 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2011-03-15 Read SEC document |
| March 15, 2004 Filed Mar 17, 2004 16:51 UTC |
LAZARUS STEVENDirector
|
GrantRestricted Common Stock | 1,643 | $0.00 | $0.00 |
DisclosureSEC source: 0001181431-04-016116 · rrd36764.xml · nonDerivative · entry 2 LAZARUS STEVEN · CIK 0001054117 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,643 F1 · security: (DIR 03.15.04) The Restricted Stock Units ("RSUs") were granted pursuant to the Amgen Inc. Director Equity Incentive Program under the Company's Amended and Restated 1991 Equity Incentive Plan. RSUs vest (a) immediately for directors who have three years or more of prior continuous service as a director, or (b) one year from the grant date if the director had had less than three years of prior continuous service as a director. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis unless payment is otherwise deferred by the director. Read SEC document |
| March 08, 2004 Filed Mar 9, 2004 23:57 UTC |
SCHAEFFER LEONARD DDirector
|
GrantNQSO(Right to Buy · Derivative | 20,000 | $0.00 Strike: $62.46 | $0.00 |
DisclosureSEC source: 0001181431-04-014762 · rrd36171.xml · derivative · entry 1 SCHAEFFER LEONARD D · CIK 0001016369 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2011-03-08 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.